Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-03-08-Speech-2-169-000"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20110308.22.2-169-000"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Madam President, one of the key conclusions drawn in the report we have voted through on evaluation of the management of H1N1 influenza is the lack of an independent evaluation carried out by national and European healthcare bodies. This results in ill-advised public health decisions. It is alarming that, in the opinion of the former ECDC director, Zsuzsanna Jakab, never before had a vaccine been granted a marketing authorisation with so few data available on its effects. She said this in response to a question on the safety of adjuvants in the vaccine against the H1N1 pandemic. Greater transparency is needed for decisions which affect human health. In Poland, the health minister decided not to purchase vaccines or implement a vaccination programme, in spite of pressure from the media and many other groups. One could be forgiven for wondering how stressful it was for the citizens bombarded with information on a daily basis telling them that they should be vaccinated. One could also be forgiven for wondering whether it is ethical to be focused exclusively on profit, and to neglect the health of citizens and, as a result, also undermine trust in official recommendations on vaccinations, which are intended to protect us against epidemics. Thank you very much."@en1
|
| lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples